JP2006513238A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513238A5
JP2006513238A5 JP2004565235A JP2004565235A JP2006513238A5 JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5 JP 2004565235 A JP2004565235 A JP 2004565235A JP 2004565235 A JP2004565235 A JP 2004565235A JP 2006513238 A5 JP2006513238 A5 JP 2006513238A5
Authority
JP
Japan
Prior art keywords
iminoethyl
cysteine
ethyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004565235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038792 external-priority patent/WO2004060352A1/en
Publication of JP2006513238A publication Critical patent/JP2006513238A/ja
Publication of JP2006513238A5 publication Critical patent/JP2006513238A5/ja
Pending legal-status Critical Current

Links

JP2004565235A 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤 Pending JP2006513238A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43502202P 2002-12-19 2002-12-19
US43542202P 2002-12-19 2002-12-19
US43514702P 2002-12-19 2002-12-19
PCT/US2003/038792 WO2004060352A1 (en) 2002-12-19 2003-12-05 Non-hygroscopic formulation comprising a hydroscopic drug

Publications (2)

Publication Number Publication Date
JP2006513238A JP2006513238A (ja) 2006-04-20
JP2006513238A5 true JP2006513238A5 (enExample) 2006-08-10

Family

ID=32719157

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004565235A Pending JP2006513238A (ja) 2002-12-19 2003-12-05 吸湿性薬物を含む非‐吸湿性製剤
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および／または潮解性の薬剤を含む固体分散剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004565403A Withdrawn JP2006514052A (ja) 2002-12-19 2003-12-11 吸湿性および／または潮解性の薬剤を含む固体分散剤

Country Status (17)

Country Link
US (2) US20040197411A1 (enExample)
EP (2) EP1575563B1 (enExample)
JP (2) JP2006513238A (enExample)
AR (2) AR042511A1 (enExample)
AT (1) ATE353633T1 (enExample)
AU (2) AU2003298010A1 (enExample)
BR (2) BR0317392A (enExample)
CA (2) CA2511385A1 (enExample)
DE (1) DE60311875T2 (enExample)
ES (1) ES2280835T3 (enExample)
HN (1) HN2003000417A (enExample)
MX (2) MXPA05006802A (enExample)
NL (1) NL1025069C2 (enExample)
PE (1) PE20040972A1 (enExample)
TW (2) TW200423971A (enExample)
UY (1) UY28138A1 (enExample)
WO (2) WO2004060352A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (da) 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter
ATE228358T1 (de) * 2001-03-21 2002-12-15 Sanol Arznei Schwarz Gmbh Neue verwendung einer klasse von peptidverbindungen zur behandlung von allodynie oder andere arten von chronischen oder phantomschmerzen
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
JP2006513238A (ja) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤
ATE359075T1 (de) * 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
FR2865133B1 (fr) * 2004-01-19 2008-01-18 Rytek Compositions pour le traitement de pathologies digestives
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
JP2007532607A (ja) 2004-04-16 2007-11-15 シュバルツ　ファルマ　アクチェンゲゼルシャフト 慢性頭痛の予防及び治療のためのペプチド化合物の使用
EP1765309B1 (en) * 2004-07-02 2009-08-05 Radi Medical Biodegradable AB Smokeless toabacco product
ATE471717T1 (de) * 2004-08-27 2010-07-15 Ucb Pharma Gmbh Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
US20090304786A1 (en) * 2005-11-25 2009-12-10 Viswaprasad Varanasi Stable Dosage Forms of an Antidepressant
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
RU2406502C2 (ru) * 2006-06-06 2010-12-20 Тиботек Фармасьютикалз Лтд. Способ получения препаратов тмс125, полученных сушкой распылением
EP2037965B1 (en) 2006-06-15 2017-08-30 UCB Pharma GmbH Pharmaceutical composition with synergistic anticonvulsant effect
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
CA2673536A1 (en) * 2006-12-22 2008-07-03 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
US9358242B2 (en) * 2007-08-30 2016-06-07 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
CA2701388C (en) * 2007-08-30 2015-06-23 Prelief Inc. Calcium glycerophosphate for treating and preventing respiratory diseases or conditions
KR101499533B1 (ko) * 2008-02-15 2015-03-09 주식회사 씨티씨바이오 콜린 알포세레이트 함유 약학 제제
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
KR101172699B1 (ko) 2011-05-16 2012-08-09 한국프라임제약주식회사 콜린알포세레이트를 함유하는 약학 제제, 및 그의 제조방법
JP2014522893A (ja) 2011-07-07 2014-09-08 ザ ルブリゾル コーポレイション ２ストロークサイクルエンジンのための改善された清浄性を提供する潤滑剤
CN102525992A (zh) * 2012-03-09 2012-07-04 徐奎 L-α-甘油磷酸胆碱薄膜衣片及其制备方法
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
WO2013175505A1 (en) * 2012-05-21 2013-11-28 Hetero Research Foundation Elvitegravir solid dispersion
HRP20251029T1 (hr) 2013-07-19 2025-10-24 Boehringer Ingelheim Vetmedica Gmbh Konzervirani eterificirani derivati ciklodekstrina koji sadrže tekući vodeni farmaceutski pripravak
PL3106150T3 (pl) * 2013-12-04 2022-01-03 Boehringer Ingelheim Vetmedica Gmbh Ulepszone kompozycje farmaceutyczne pimobendanu
GB2525170A (en) * 2014-04-07 2015-10-21 Nokia Technologies Oy Stereo viewing
CN104739776A (zh) * 2015-04-15 2015-07-01 福州乾正药业有限公司 左卡尼汀的固体分散体组合物及其制备方法和药物应用
WO2017013591A1 (en) * 2015-07-22 2017-01-26 Leiutis Pharmaceuticals Pvt Ltd Stabilized liquid formulation of levothyroxine
BR112018068986B1 (pt) * 2016-03-18 2023-03-21 Christopher Brian Reid Composição para reduzir a expressão oncógena de uma célula, tecido ou órgão de um indivíduo
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
JP7319247B2 (ja) * 2018-03-30 2023-08-01 株式会社カネカ 酸化型グルタチオンを含む固体組成物及びその製造方法
CN112316678A (zh) * 2020-10-12 2021-02-05 常州市永勃机械有限公司 一种变电站柜体用驱潮剂制备工艺制备方法
IT202100018578A1 (it) * 2021-07-14 2023-01-14 Indena Spa Dispersione amorfa di maltolo ferrico e relativo processo di preparazione

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPH02218621A (ja) * 1989-02-20 1990-08-31 Nippon Chemiphar Co Ltd 徐放性製剤
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5688510A (en) * 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
JPH08157392A (ja) * 1994-12-01 1996-06-18 Kanegafuchi Chem Ind Co Ltd 放出制御型製剤
GB9607955D0 (en) * 1996-04-17 1996-06-19 Tillotts Pharma Ag Hydrophobic carbomer salt compositions
JPH10182448A (ja) * 1996-12-24 1998-07-07 Zensei Yakuhin Kogyo Kk 圧縮製剤用組成物の製造方法
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
ZA200206459B (en) * 2000-03-24 2003-08-13 Pharmacia Corp Amidino compound and salts thereof useful as nitric oxide synthase inhibitors.
US20020143058A1 (en) * 2001-01-24 2002-10-03 Taro Pharmaceutical Inductries Ltd. Process for preparing non-hygroscopic sodium valproate composition
JP2006513238A (ja) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤

Similar Documents

Publication Publication Date Title
JP2006513238A5 (enExample)
JP2003213038A5 (enExample)
RU2302408C3 (ru) Гидроксаматные производные, применимые в качестве ингибиторов дезацетилазы
JP2007519619A5 (enExample)
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
JP2005330280A5 (enExample)
KR930016389A (ko) No 신타제 및 시클로옥시게나제의 이중 억제제, 이들의 제조방법 및 이들을 함유하는 치료 조성물
DK1144368T3 (da) Acetyleniske alfa-aminosyrebaserede sulfonamid-hydroxamsyre-TACE-inhibitorer
JP2009501177A5 (enExample)
JP2009501178A5 (enExample)
HRP20140986T1 (hr) Polimorfni oblik derivata 2-amino(nitroaril)tiazola
JP2014012726A5 (enExample)
JP2007504212A5 (enExample)
AR041053A1 (es) Derivados de dioxan-2-alquilcarbamatos, su preparacion y su aplicacion de terapeutica
JP2003510285A5 (enExample)
JP2004315384A5 (enExample)
JP2021123009A5 (enExample)
NO20034236L (no) Ny fremgangsmate for den industrielle syntese av tetraestere av 5-[bis(karboksymetyl)amino]-3-karboksymetyl-4-cyano-2-tiofenkarboksylsyre, og anvendelse i syntesen av bivalente salter av ranelinsyre og deres hydrater
JP2006276598A5 (enExample)
JP2005522492A5 (enExample)
RU2412935C2 (ru) Феноксиуксусные кислоты в качестве активаторов дельта рецепторов ppar
JP2004532624A5 (enExample)
JP2010512326A5 (enExample)
JPH09235233A5 (enExample)
JP2004523545A5 (enExample)